Publications by authors named "Sandeep Dutta"

Claim this Profile
P
Population Pharmacokinetics of Sotorasib in Healthy Subjects and Advanced Solid Tumor Patients Harboring a KRAS Mutation from Phase 1 and Phase 2 Studies.
Mario Nagase, Brett Houk, Irene Vuu, Panli Cardona, Sandeep Dutta

AAPS J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a High-Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C Inhibitor.
Panli Cardona, Sandeep Dutta, Brett Houk

Clin Pharmacol Drug Dev· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of Sotorasib.
Panli Cardona, Sandeep Dutta, Brett Houk

Clin Pharmacol Drug Dev· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA-Based Therapeutics Using a Mechanistic Physiologically-Based Pharmacokinetic-Pharmacodynamic Model.
Annie Lumen, Xinwen Zhang, Sandeep Dutta, Vijay V Upreti

Clin Pharmacol Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of youth sport participation to physical activity levels and cardiovascular disease risk factors in 5-year-old to 14-year-old children: a study protocol for systematic review and meta-analysis.
Paola A Fernández Solá, Janette M Watkins, Aidrik Grube, Sarah J Greeven, Sandeep Dutta

BMJ Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting Delta-Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC).
Di Zhou, Lauren A Byers, Beate Sable, Marie-Anne Damiette Smit, Nooshin Hashemi Sadraei, Sandeep Dutta

J Clin Pharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mechanistic Physiologically-Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell Engagers.
Xinwen Zhang, Annie Lumen, Hansen Wong, Jamie Connarn, Sandeep Dutta

Clin Pharmacol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human-centered participatory co-design with children and adults for a prototype lifestyle intervention and implementation strategy in a rural middle school.
Janette M Watkins, Sarah J Greeven, Kathleen N Heeter, Julia E Brunnemer, Jacob Otile, Sandeep Dutta

BMC Public Health· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multistate platform model for time-to-event endpoints in oncology clinical trials.
Chih-Wei Lin, Mario Nagase, Sameer Doshi, Sandeep Dutta

CPT Pharmacometrics Syst Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migraine.
Po-Wei Chen, Mats O Karlsson, Sebastian Ueckert, Ari Pritchard-Bell, Cheng-Pang Hsu, Sandeep Dutta

CPT Pharmacometrics Syst Pharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilevel needs assessment of physical activity, sport, psychological needs, and nutrition in rural children and adults.
Sarah J Greeven, Andrew M Medellin, Janette M Watkins, Cassandra J Coble, Julia E Brunnemer, Sandeep Dutta

Front Public Health· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp Alfa, a Bispecific Inhibitor of BAFF and ICOSL: Analyses of Phase I Clinical Trials.
Lubna Abuqayyas, Po-Wei Chen, Marcia Teixeira Dos Santos, Jane R Parnes, Sameer Doshi, Sandeep Dutta

Clin Pharmacol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic Pharmacokinetic/Pharmacodynamic Modeling in Support of a Patient-Convenient, Longer Dosing Interval for Carfilzomib, a Covalent Inhibitor of the Proteasome.
Marc R Yago, Khamir Mehta, Maitreyee Bose, Sharvari Bhagwat, Vivek S Chopra, Sandeep Dutta

Clin Pharmacokinet· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic viral kinetics mechanistic modeling of Talimogene Laherparepvec (T-VEC) a first-in-class oncolytic viral therapy in patients with advanced melanoma.
Malidi Ahamadi, Johannes Kast, Po-Wei Chen, Xiaojun Huang, Sandeep Dutta

CPT Pharmacometrics Syst Pharmacol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T-cellular therapy development.
Johannes Kast, Saeideh Nozohouri, Di Zhou, Marc R Yago, Po-Wei Chen, Sandeep Dutta

Clin Transl Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of time to progression and post progression survival using joint modeling of summary level OS and PFS data with an ordinary differential equation model.
Mario Nagase, Sameer Doshi, Sandeep Dutta, Chih-Wei Lin

J Pharmacokinet Pharmacodyn· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Properties of Omecamtiv Mecarbil in Healthy Subjects and Patients With Heart Failure With Reduced Ejection Fraction.
Po-Wei Chen, Ashit Trivedi, Edward Lee, Sandeep Dutta, Malidi Ahamadi

J Cardiovasc Pharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects.
Ashit Trivedi, Winnie Sohn, Cheng-Pang Hsu, Pegah Jafarinasabian, Hanze Zhang, Sandeep Dutta

Clin Pharmacol Drug Dev· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Evaluation of the CYP3A4 and CYP2D6 Drug-Drug Interaction and CYP3A4 Induction Potential of Omecamtiv Mecarbil: Two Open-Label Studies in Healthy Subjects.
Ashit Trivedi, Fady I Malik, Pegah Jafarinasabian, Hanze Zhang, Stephen Flach, Sandeep Dutta

Clin Pharmacol Drug Dev· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations.
Ashit Trivedi, Cheng-Pang Hsu, Pegah Jafarinasabian, Bianca Terminello, Hanze Zhang, Sandeep Dutta

Br J Clin Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects.
Ashit Trivedi, Winnie Sohn, Pegah Jafarinasabian, Hanze Zhang, Bianca Terminello, Sandeep Dutta

Clin Pharmacol Drug Dev· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Tolerability, and Safety of Single and Multiple Omecamtiv Mecarbil Doses in Healthy Japanese and Caucasian Subjects.
Ashit Trivedi, Fady I Malik, Mia Mackowski, Shauna Hutton, Makoto Aoki, Sandeep Dutta

Eur J Drug Metab Pharmacokinet· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of drug-drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically-based pharmacokinetic model.
Ashit Trivedi, Winnie Sohn, Priyanka Kulkarni, Pegah Jafarinasabian, Hanze Zhang, Sandeep Dutta

Clin Transl Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of hepatic and renal function on panitumumab exposures in patients with metastatic RAS wild-type colorectal cancer.
Michael Z Liao, Hans Prenen, Sandeep Dutta, Vijay V Upreti

Cancer Chemother Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panitumumab: A Review of Clinical Pharmacokinetic and Pharmacology Properties After Over a Decade of Experience in Patients with Solid Tumors.
Johannes Kast, Sandeep Dutta, Vijay V Upreti

Adv Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis